Author/Creator: Joseph, George J. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Joseph, George J.

1. Annual acquisition and administration cost of biologic response modifiers per patient with rheumatoid arthritis, psoriasis, psoriatic arthritis, or ankylosing spondylitis. (17th July 2013)

Authors:: Bonafede, Machaon; Joseph, George J.; Princic, Nicole; Harrison, David J.
Journal:: Journal of medical economics
Issue:: Volume 16:Number 9(2013)
Page Start:: 1120
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Hospitalizations and healthcare costs associated with rifaximin versus lactulose treatment among commercially insured patients with hepatic encephalopathy in the United States. (1st January 2021)

Authors:: Volk, Michael L.; Burne, Rebecca; Guérin, Annie; Shi, Sherry; Joseph, George J.; Heimanson, Zeev; Ahmad, Maliha
Journal:: Journal of medical economics
Issue:: Volume 24:Number 1(2021)
Page Start:: 202
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Treatment patterns and healthcare costs among newly-diagnosed patients with chronic myeloid leukemia receiving dasatinib or nilotinib as first-line therapy in the United States. (2nd January 2017)

Authors:: Latremouille-Viau, Dominick; Guerin, Annie; Nitulescu, Roy; Gagnon, Patrick S.; Joseph, George J.; Chen, Lei
Journal:: Journal of medical economics
Issue:: Volume 20:Number 1(2017)
Page Start:: 63
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Treatment patterns, healthcare resource utilization, and costs in patients with acute myeloid leukemia in commercially insured and Medicare populations. (3rd June 2018)

Authors:: Stein, Eytan M.; Bonifacio, Gaetano; Latremouille-Viau, Dominick; Guerin, Annie; Shi, Sherry; Gagnon-Sanschagrin, Patrick; Briggs, Owanate; Joseph, George J.
Journal:: Journal of medical economics
Issue:: Volume 21:Number 6(2018)
Page Start:: 556
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Tyrosine kinase inhibitor therapy treatment and discontinuation in patients with chronic myeloid leukemia in chronic phase in the United States: a clinical practice perspective. Issue 6 (12th May 2019)

Authors:: Ritchie, Ellen K.; Latremouille-Viau, Dominick; Guerin, Annie; Pivneva, Irina; Habucky, Karen; Ndife, Briana; Joseph, George J.; Atallah, Ehab L.
Journal:: Leukemia & lymphoma
Issue:: Volume 60:Issue 6(2019)
Page Start:: 1476
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Use of a validated algorithm to estimate the annual cost of effective biologic treatment for rheumatoid arthritis. (August 2014)

Authors:: Curtis, Jeffrey R.; Schabert, Vernon F.; Yeaw, Jason; Korn, Jonathan R.; Quach, Caroleen; Harrison, David J.; Yun, Huifeng; Joseph, George J.; Collier, David
Journal:: Journal of medical economics
Issue:: Volume 17:Number 8(2014)
Page Start:: 555
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗